• Factors ID’d for Strong Antibody Response in COVID-19

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health October 26, 2020
  • COVID-19 Pandemic Challenges Osteoporosis Management

    Healthday News COVID-19, Family Practice, Geriatrics, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health October 26, 2020
  • AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy October 26, 2020
  • Survival From COVID-19 High in Patients With Psoriasis

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, Pharmacy October 23, 2020
  • FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy October 23, 2020

Sponsored by Janssen Pharmaceuticals, Inc. Intended for Healthcare Professionals

covid19.healthcare.pro
Navigation
  • COVID-19
  • Latest News
  • Travel Vaccine News
  • Influenza Vaccine News
  • Search
  • COVID-19
  • Latest News
  • Travel Vaccine News
  • Influenza Vaccine News
  • Search
Home Articles ANAP

Tag Archive

  • COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health / October 26, 2020

    Factors ID’d for Strong Antibody Response in COVID-19

    View Post
  • COVID-19, Family Practice, Geriatrics, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health / October 26, 2020

    COVID-19 Pandemic Challenges Osteoporosis Management

    View Post
  • COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy / October 26, 2020

    AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials

    View Post
  • COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, Pharmacy / October 23, 2020

    Survival From COVID-19 High in Patients With Psoriasis

    View Post
  • COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy / October 23, 2020

    FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say

    View Post
View Post

2.5 Anaphylaxis Cases Reported Per Million COVID-19 Moderna Vaccine Shots

In COVID-19, Latest News
by Healthday
January 25, 2021

Nine of the 10 cases occurred in individuals with documented history of allergies, allergic reactions

View Post

Allergists Affirm Safety of COVID-19 Vaccines for Most

In COVID-19, Latest News
by Healthday
January 7, 2021

All patients should be observed for 15 minutes after vaccination; staff should be trained in anaphylaxis management

View Post

11.1 Anaphylaxis Cases/Million Doses of Pfizer-BioNTech COVID-19 Vaccine Reported

In COVID-19, Latest News
by Healthday
January 7, 2021

Median interval from vaccine receipt to symptom onset was 13 minutes

View Post

ACAAI: Reaction to COVID-19 Vaccine Unlikely for Those With Common Allergies

In COVID-19, Latest News
by Healthday
December 18, 2020

Pfizer COVID-19 vaccine should not be administered to individuals with a known history of severe reaction to polyethylene glycol

TRENDING

  • Thousands of Airport Screeners Needed in the USA
  • Risk Reduced for Positive NAAT Result With SARS-CoV-2 Antibodies
  • U.S. FDA Issues New Guidance to Medical Product Developers Addressing Virus Variants
  • Ebola Vaccinations Launch in Western Africa
  • Children Given Flu Shot Less Likely to Have Symptomatic COVID-19

By Publish Date

February 2021
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
« Jan    

LATEST ARTICLES

  • Thousands of Airport Screeners Needed in the USA February 25, 2021
  • Risk Reduced for Positive NAAT Result With SARS-CoV-2 Antibodies February 25, 2021
  • U.S. FDA Issues New Guidance to Medical Product Developers Addressing Virus Variants February 24, 2021

Sponsored by Janssen Pharmaceuticals, Inc. Intended for U.S. Healthcare Professionals.

Powered by eHealthcare Solutions. | Privacy Policy

  • COVID-19
  • Travel Vaccine News
  • Family Practice
  • OBGYN & Women’s Health
  • Clinical Guidelines